EUVIMEDEUVIMED entdecken
Crossref

Targeting lipid nanoparticle mediated co-delivery of edaravone and kaempferol for amyotrophic lateral sclerosis therapy

Junrong Tian, Zhuanzhuan Jin, Yike Chi, Pu Wang, Huili Sun

Nanoscale · 2026

DOI: 10.1039/d6nr00300a ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nanoscale, 2026. Verfasst von Junrong Tian und 4 weiteren Autor:innen. Beteiligte Einrichtung: Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs, School of Life Science and Engineering, Southwest Jiaotong University,…. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Edaravone, Kaempferols, Nanoparticles. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Department of Science and Technology of Sichuan Province, Fundamental Research Funds for Central Universities of the Central South University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A cRGD-modified lipid nanomedicine encapsulating edaravone and kaempferol achieves BBB penetration and neuronal targeting. Nrf2/SLC7A11/GPX4 signaling was activated, inhibiting ferroptosis and neuronal damage, offering a strategy for ALS treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisEdaravoneKaempferolsNanoparticlesAnimalsMiceMice, TransgenicHumansLiposomesBlood-Brain BarrierFerroptosisSuperoxide Dismutase-1

Substanzen

EdaravoneKaempferolskaempferolLiposomesSuperoxide Dismutase-1Lipid Nanoparticles

Autor:innen und Institutionen

  • Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs, School of Life Science and Engineering, Southwest Jiaotong University, Chengdu, Sichuan 610031, P. R. China. Huilisun@swjtu.edu.cn.
  • School of Life Sciences and Engineering, Chengdu Medical College, Chengdu, Sichuan 610500, P. R. China.
  • Department of Neurology, Chengdu Wenjiang District People's Hospital, Chengdu, Sichuan 611130, P. R. China.

Förderung

  • National Natural Science Foundation of China
  • Department of Science and Technology of Sichuan Province
  • Fundamental Research Funds for Central Universities of the Central South University

Zitieren

APA

Tian, J., Jin, Z., Chi, Y., Wang, P., & Sun, H. (2026). Targeting lipid nanoparticle mediated co-delivery of edaravone and kaempferol for amyotrophic lateral sclerosis therapy. Nanoscale. https://doi.org/10.1039/d6nr00300a

Vancouver

Tian J, Jin Z, Chi Y, Wang P, Sun H. Targeting lipid nanoparticle mediated co-delivery of edaravone and kaempferol for amyotrophic lateral sclerosis therapy. Nanoscale. 2026. doi:10.1039/d6nr00300a

BibTeX
@article{Tian2026,
  author = {Tian, Junrong and Jin, Zhuanzhuan and Chi, Yike and Wang, Pu and Sun, Huili},
  title = {Targeting lipid nanoparticle mediated co-delivery of edaravone and kaempferol for amyotrophic lateral sclerosis therapy},
  journal = {Nanoscale},
  year = {2026},
  doi = {10.1039/d6nr00300a}
}
Kostenlos starten →